Teva’s New York Opioid Liability Climbs To $523m With Settlement Deal

President And CEO Kåre Schultz: ‘We Are Quite Satisfied With Outcome’

 
• By Dean Rudge
  
Brian Overcast/Alamy Stock Photo
Teva had lost a jury trial in new york • Source: Shutterstock (Brian Overcast / Alamy Stock Pho/Alamy Stock Photo)
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business